Suppr超能文献

补体在炎症性疾病中的作用从幕后走向了聚光灯下。

The role of complement in inflammatory diseases from behind the scenes into the spotlight.

作者信息

Markiewski Maciej M, Lambris John D

机构信息

Department of Pathology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Am J Pathol. 2007 Sep;171(3):715-27. doi: 10.2353/ajpath.2007.070166. Epub 2007 Jul 19.

Abstract

Our understanding of the biology of the complement system has undergone a drastic metamorphosis since its original discovery. This system, which was traditionally primarily described as a "complement" to humoral immunity, is now perceived as a central constituent of innate immunity, defending the host against pathogens, coordinating various events during inflammation, and bridging innate and adaptive immune responses. Complement is an assembly of proteins found in the blood and body fluids and on cell surfaces. Soluble complement components form the proteolytic cascade, whose activation leads to the generation of complement effectors that target various cells involved in the immune response. Membrane-bound receptors and regulators transmit signals from complement effectors to target cells and limit complement activation to the surfaces of pathogens and damaged or activated host cells. The multiple interconnections among complement proteins, immune cells, and mediators provide an excellent mechanism to protect the organism against infections and support the repair of damaged tissues. However, disturbances in this "defense machinery" contribute to the pathogenesis of various diseases. The role of complement in various inflammatory disorders is multifaceted; for example, the activation of complement can significantly contribute to inflammation-mediated tissue damage, whereas inherited or acquired complement deficiencies highly favor the development of autoimmunity.

摘要

自补体系统最初被发现以来,我们对其生物学特性的理解经历了巨大的转变。该系统传统上主要被描述为体液免疫的“补充”,现在则被视为固有免疫的核心组成部分,可保护宿主抵御病原体,在炎症过程中协调各种事件,并连接固有免疫和适应性免疫反应。补体是存在于血液、体液及细胞表面的一组蛋白质。可溶性补体成分形成蛋白水解级联反应,其激活会导致补体效应分子的产生,这些效应分子作用于参与免疫反应的各种细胞。膜结合受体和调节蛋白将补体效应分子的信号传递给靶细胞,并将补体激活限制在病原体表面以及受损或活化的宿主细胞表面。补体蛋白、免疫细胞和介质之间的多重相互联系为保护机体免受感染及支持受损组织修复提供了绝佳机制。然而,这种“防御机制”的紊乱会导致多种疾病的发病机制。补体在各种炎症性疾病中的作用是多方面的;例如,补体激活可显著导致炎症介导的组织损伤,而遗传性或获得性补体缺陷则极有利于自身免疫性疾病的发展。

相似文献

1
The role of complement in inflammatory diseases from behind the scenes into the spotlight.
Am J Pathol. 2007 Sep;171(3):715-27. doi: 10.2353/ajpath.2007.070166. Epub 2007 Jul 19.
2
Self, non-self, and danger: a complementary view.
Adv Exp Med Biol. 2006;586:71-94. doi: 10.1007/0-387-34134-X_6.
3
Anaphylatoxins spark the flame in early autoimmunity.
Front Immunol. 2022 Jul 25;13:958392. doi: 10.3389/fimmu.2022.958392. eCollection 2022.
4
Molecules Great and Small: The Complement System.
Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1636-50. doi: 10.2215/CJN.06230614. Epub 2015 Jan 7.
5
The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.
Inflamm Allergy Drug Targets. 2009 Jul;8(3):236-46. doi: 10.2174/187152809788681038.
6
Complement: Bridging the innate and adaptive immune systems in sterile inflammation.
J Leukoc Biol. 2020 Jul;108(1):339-351. doi: 10.1002/JLB.3MIR0220-270R. Epub 2020 Mar 17.
7
Complement and autoimmunity.
Immunol Res. 2013 Jul;56(2-3):477-91. doi: 10.1007/s12026-013-8422-y.
8
The complement system.
Cell Tissue Res. 2011 Jan;343(1):227-35. doi: 10.1007/s00441-010-1034-0. Epub 2010 Sep 14.
9
Complement as a diagnostic tool in immunopathology.
Semin Cell Dev Biol. 2019 Jan;85:86-97. doi: 10.1016/j.semcdb.2017.12.017. Epub 2018 Jan 12.
10
Anaphylatoxins: their role in bacterial infection and inflammation.
Immunol Res. 2007;37(3):161-75. doi: 10.1007/BF02697367.

引用本文的文献

1
The complement system in human pregnancy and preeclampsia.
Front Immunol. 2025 Aug 19;16:1617140. doi: 10.3389/fimmu.2025.1617140. eCollection 2025.
2
The role of complement in long COVID pathogenesis.
JCI Insight. 2025 Aug 22;10(16). doi: 10.1172/jci.insight.194314.
7
Impact of smoking on the complement system: a narrative review.
Front Immunol. 2025 Jun 19;16:1619835. doi: 10.3389/fimmu.2025.1619835. eCollection 2025.
8
Construction and validation of HBV-ACLF bacterial infection diagnosis model based on machine learning.
BMC Infect Dis. 2025 Jul 1;25(1):847. doi: 10.1186/s12879-025-11199-5.
9
Immune-mediated renal injury in diabetic kidney disease: from mechanisms to therapy.
Front Immunol. 2025 Jun 4;16:1587806. doi: 10.3389/fimmu.2025.1587806. eCollection 2025.

本文引用的文献

1
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):240-5. doi: 10.1073/pnas.0603420103. Epub 2006 Dec 20.
2
Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans.
J Biol Chem. 2007 Jan 26;282(4):2520-8. doi: 10.1074/jbc.M607848200. Epub 2006 Nov 27.
3
Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury.
J Immunol. 2006 Oct 1;177(7):4727-34. doi: 10.4049/jimmunol.177.7.4727.
5
Generation of C5a in the absence of C3: a new complement activation pathway.
Nat Med. 2006 Jun;12(6):682-7. doi: 10.1038/nm1419. Epub 2006 May 21.
6
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.
Blood. 2006 Aug 15;108(4):1267-79. doi: 10.1182/blood-2005-10-007252. Epub 2006 Apr 18.
7
Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.
EMBO J. 2006 Apr 19;25(8):1784-94. doi: 10.1038/sj.emboj.7601052. Epub 2006 Apr 6.
9
Drusen complement components C3a and C5a promote choroidal neovascularization.
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2328-33. doi: 10.1073/pnas.0408835103. Epub 2006 Feb 1.
10
The central role of the alternative complement pathway in human disease.
J Immunol. 2006 Feb 1;176(3):1305-10. doi: 10.4049/jimmunol.176.3.1305.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验